Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on August 26, 2026

3 hours ago

Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery

Indeterminate GlobeNewswire

3 hours ago

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire

3 hours ago

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 

Indeterminate GlobeNewswire

3 hours ago

NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3

Indeterminate GlobeNewswire

3 hours ago

Candel Therapeutics to Present at September Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

Indeterminate GlobeNewswire

3 hours ago

Guidelight Health Virtual Brings Evidence-Based Mental Health Care to All of Colorado, Massachusetts and North Carolina

Indeterminate GlobeNewswire

3 hours ago

NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

3 hours ago

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent

Indeterminate GlobeNewswire

3 hours ago

FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development

Indeterminate GlobeNewswire

3 hours ago

CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities

Indeterminate GlobeNewswire

3 hours ago

BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

Indeterminate GlobeNewswire

3 hours ago

Tvardi Therapeutics to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire

3 hours ago

Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers

Indeterminate GlobeNewswire

4 hours ago

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire

4 hours ago

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

4 hours ago

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Indeterminate GlobeNewswire